USANA Health Sciences, Inc.
USNA
$33.06
$0.100.30%
| 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 200.22M | 212.87M | 227.80M | 221.08M | 213.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 200.22M | 212.87M | 227.80M | 221.08M | 213.37M |
| Cost of Revenue | 39.26M | 40.33M | 43.07M | 42.32M | 42.53M |
| Gross Profit | 160.96M | 172.54M | 184.73M | 178.76M | 170.84M |
| SG&A Expenses | 145.36M | 154.70M | 160.06M | 154.55M | 153.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 184.62M | 195.03M | 203.13M | 196.86M | 195.76M |
| Operating Income | 15.60M | 17.84M | 24.67M | 24.22M | 17.61M |
| Income Before Tax | 18.61M | 20.20M | 27.11M | 26.61M | 20.53M |
| Income Tax Expenses | 8.00M | 9.77M | 10.57M | 9.85M | 9.18M |
| Earnings from Continuing Operations | 10.61M | 10.43M | 16.54M | 16.77M | 11.35M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.61M | 10.43M | 16.54M | 16.77M | 11.35M |
| EBIT | 15.60M | 17.84M | 24.67M | 24.22M | 17.61M |
| EBITDA | 19.17M | 21.65M | 27.83M | 27.13M | 20.88M |
| EPS Basic | 0.56 | 0.55 | 0.86 | 0.87 | 0.59 |
| Normalized Basic EPS | 0.61 | 0.66 | 0.88 | 0.86 | 0.67 |
| EPS Diluted | 0.56 | 0.54 | 0.86 | 0.87 | 0.59 |
| Normalized Diluted EPS | 0.61 | 0.66 | 0.88 | 0.86 | 0.66 |
| Average Basic Shares Outstanding | 19.08M | 19.07M | 19.17M | 19.25M | 19.25M |
| Average Diluted Shares Outstanding | 19.08M | 19.16M | 19.30M | 19.25M | 19.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
